cilazapril, anhydrous has been researched along with Diabetes Mellitus, Type 2 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiselevich, A; London, D; Magen, E; Priluk, R; Viskoper, RJ; Volchek, L; Yosefy, C | 1 |
| Bilo, HJ; Donker, AJ; Gans, RO; Goggin, T; Kraaij, CJ; Stehouwer, CD; van der Veen, EA | 1 |
| Acampora, R; Cacciapuoti, F; D'Onofrio, F; De Rosa, N; Di Maro, G; Giugliano, D; Marfella, R; Quatraro, A | 1 |
| Brocco, E; Carraro, A; Cernigoi, AM; Fioretto, P; Fresu, P; Frigato, F; Maioli, M; Muollo, B; Nosadini, R; Tonolo, G; Velussi, M; Zolli, M | 1 |
| Le Bloch, Y; Waeber, B; Weidmann, P; Wohler, D | 1 |
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S | 1 |
| Half-Onn, E; Levi, Z; Rachmani, R; Ravid, M; Slavachevsky, I | 1 |
| Ebihara, I; Koide, H; Nakamura, T; Shimada, N | 1 |
| Delles, C; Hilgers, KF; Schmieder, RE; Veelken, R | 1 |
| Dotzer, F | 1 |
| Ebina, T; Gotoh, E; Ishii, M; Matsukawa, T; Minamisawa, K; Shionoiri, H; Sugimoto, K; Ueda, S | 1 |
| Ben-Ishay, D; Bursztyn, M; Fidel, J; Kobrin, I | 1 |
1 review(s) available for cilazapril, anhydrous and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[ACE inhibition with cilazapril. Major therapeutic aspects: hypertension and metabolic syndrome].
Topics: Cilazapril; Diabetes Mellitus, Type 2; Humans; Hypertension; Long-Term Care | 1992 |
6 trial(s) available for cilazapril, anhydrous and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.
Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation | 2004 |
Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Cilazapril; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged | 1993 |
Comparison of nitrendipine and cilazapril in patients with hypertension and non-insulin-dependent diabetes mellitus.
Topics: Blood Pressure; Cilazapril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Time Factors | 1993 |
Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Glomerular Filtration Rate; Humans; Hypertension; Middle Aged; Proteinuria | 1996 |
Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cilazapril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Doxazosin; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Male; Middle Aged | 1998 |
Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Edema; Female; Follow-Up Studies; Humans; Hypertension, Renal; Male; Middle Aged; Patient Selection; Prospective Studies; Proteinuria; Treatment Outcome | 2001 |
5 other study(ies) available for cilazapril, anhydrous and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Topics: Adolescent; Adult; Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 1996 |
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains | 1997 |
Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cilazapril; Collagenases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Hypertension, Renovascular; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Middle Aged; Severity of Illness Index; Time Factors; Tissue Inhibitor of Metalloproteinase-1 | 1998 |
Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Cholesterol; Cilazapril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Pyridazines; Triglycerides | 1990 |
Improved kidney function with cilazapril in hypertensive type II diabetics with chronic renal failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Pyridazines | 1991 |